Fine particle design and preparations for pulmonary drug delivery

DOI Web Site 1 Citations 27 References
  • Tozuka Yuichi
    Laboratory of Pharmaceutical Engineering, Department of Drug Delivery Technology and Science, Gifu Pharmaceutical University
  • Takeuchi Hirofumi
    Laboratory of Pharmaceutical Engineering, Department of Drug Delivery Technology and Science, Gifu Pharmaceutical University

Bibliographic Information

Other Title
  • 経肺投与を目指した微粒子設計および薬物微粒化技術
  • ケイハイ トウヨ オ メザシタ ビリュウシ セッケイ オヨビ ヤクブツ ビリュウカ ギジュツ

Search this article

Abstract

Pulmonary drug administration has many advantages over other delivery routes in both local and systemic drug delivery, since the lungs have a large surface area, thin absorption barrier and low enzymatic metabolic activity. We have reported several methods to design and prepare the submicron-sized particles suitable for nebulization or dry powder inhalation. Elcatonin loaded surface-modified DL-lactide/glycolide copolymer (PLGA) nanospheres coated with chitosan (CS) were prepared by the emulsion solvent diffusion method for pulmonary delivery of peptide. The resultant CS-modified PLGA nanospheres were confirmed to improve the pulmonary delivery of peptide with a nebulization system. With respect to the dry powder inhalation, nanoparticles of drugs could be obtained by a novel supercritical carbon dioxide method with a combination of supercritical antisolvent precipitation and rapid expansion from supercritical to aqueous solution. The resulting particles showed superior inhalation properties in an in vitro inhalation test using the cascade impactor. Nanotechnology focusing at particle design to control the particle size and surface properties may be a promising tool for developing effective pulmonary delivery systems.

Journal

  • Drug Delivery System

    Drug Delivery System 23 (4), 467-473, 2008

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

Citations (1)*help

See more

References(27)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top